Back
Madrigal Pharmaceuticals Stock Predictions
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
46
MDGL
Madrigal Pharmaceuticals
Last Price:
$291.14
Seasonality Move:
-7.12%
7 Day Trial
ALL ACCESS PASS
$
7
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.Madrigal Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Madrigal Pharmaceuticals has on average historically risen by 45.9% based on the past 18 years of stock performance.
-
Madrigal Pharmaceuticals has risen higher in 7 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 38.89%
-
Is Madrigal Pharmaceuticals Stock Undervalued?The current Madrigal Pharmaceuticals [MDGL] share price is $290.96. The Score for MDGL is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
MDGL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Madrigal Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Madrigal Pharmaceuticals has on average historically risen by 45.9% based on the past 18 years of stock performance.
Madrigal Pharmaceuticals Stock Rating
Sell
46
Madrigal Pharmaceuticals (MDGL)
is a Sell
Is Madrigal Pharmaceuticals overpriced?
-
Madrigal Pharmaceuticals has risen higher in 7 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 38.89%
Madrigal Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
madrigalpharma.com
52-Week Data
52-Week High:
377.46
52-Week Low:
200.63
Prediction Charts
Market Cap:
6.5B
Price in USD:
290.96
Volume:
293.3K
Beta:
1.11
Technical Analysis
SMA50:
319.52
SMA100:
320.93
SMA200:
292.14
52-Wk Change:
33.98%
Stock Predictions
-
Is Madrigal Pharmaceuticals stock public?Yes, Madrigal Pharmaceuticals is a publicly traded company.
-
What is the Madrigal Pharmaceuticals stock quote today?The Madrigal Pharmaceuticals stock price is 290.96 USD today.
-
How to buy Madrigal Pharmaceuticals stock online?You can buy Madrigal Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-29 | 331.29 | 340.80 | 344.55 | 326.56 |
| Apr-30 | 332.16 | 333.91 | 345.73 | 331.25 |
| May-1 | 349.00 | 327.70 | 349.00 | 312.52 |
| May-2 | 329.86 | 315.48 | 337.52 | 313.42 |
| May-5 | 316.00 | 306.38 | 318.27 | 304.50 |
| May-6 | 301.65 | 295.13 | 305.28 | 294.23 |
| May-7 | 297.33 | 298.83 | 299.58 | 287.46 |
| May-8 | 298.81 | 299.57 | 304.47 | 291.00 |
| May-9 | 300.11 | 294.64 | 307.49 | 291.16 |
| May-12 | 295.04 | 300.76 | 307.54 | 295.04 |
| May-13 | 300.00 | 295.36 | 306.15 | 293.76 |
| May-14 | 295.00 | 282.86 | 301.16 | 280.68 |
| May-15 | 283.95 | 291.82 | 291.97 | 280.00 |
| May-16 | 292.44 | 290.96 | 294.40 | 288.00 |
Madrigal Pharmaceuticals Earnings
Madrigal Pharmaceuticals Earnings Report: Per Share Madrigal Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Madrigal Pharmaceuticals Forecast Revenue Growth
Madrigal Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Madrigal Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $3.44 per share, an increase next quarter of $1.75 per share, an increase this year of $10.92 per share, and an increase next year of $12.76 per share.
* Madrigal Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.